Global Statistics Representing Acute Sinusitis Market Scenario
Acute sinusitis, also known as acute rhinosinusitis, is a medical condition in which the cavities around the nasal passage gets swollen and inflamed. This infection impedes with the drainage of the mucus to an extent where it builds around the sinuses. Moreover, cold-causing viral infection can cause acute sinusitis, and the symptoms of the infection include nasal congestion, sore throat, toothache, bad breath, and reduced sense of smell and taste among others. The symptoms of this infection should not be ignored as it can negatively impact on the quality of life, and can get worse with time. In extreme cases, the sinus may need to be surgically removed, which will further increase the medical visits and healthcare spending.
In the U.S., the prevalence of acute sinusitis is increasing at an alarming rate. As per the Centers for Disease Control and Prevention (CDC), around 26.9 million people were diagnosed with sinusitis in the U.S. To address to this situation, government and the manufacturers are working together to provide better treatment solutions, and are also heavily investing in the technological advancements. In addition, increasing preference for over the counter medications like decongestants, nasal sprays, and nasal corticosteroids are also anticipated to fuel the growth of the market in the years to come.
Lack of awareness about acute sinusitis is one of the biggest issue faced by the developing countries, which might negatively impact the market growth in these nations. Moreover, the longer approval time for clinical trials and drugs by FDA another challenge faced by the pharmaceutical companies.
Global acute sinusitis market was valued at USD 2,042.1 million in 2018 and is expected to grow at a CAGR of 7.1% during the forecast period, 2019–2026.
The global acute sinusitis market is segmented by treatment, end-user, and region.
Based on treatment, the market is segmented into diagnosis and medication. Diagnosis is further segmented into imaging test, allergy test, nasal endoscopy, and laboratory test. Imaging is further divided into computed tomography and magnetic resonance imaging. Magnetic resonance imaging allows better differentiation of soft tissue structures within the sinuses as it uses strong magnetic fields and radio waves to produce internal images of the body. In addition, MRI is a non-invasive way to view inflammation, and other structures inside the body, which is further boosting the segment growth.
Medication is sub-segmented into a saline nasal spray, nasal corticosteroids, decongestant, antibiotics, OTC pain relievers, and allergy shots among others. Nasal corticosteroids segment is expected to hold major market share as it is very effective at reducing inflammation. It is widely used to relieve symptoms such as sinus congestion, mucus production, and nasal swelling.
In terms of end-user, the market is segmented into hospitals & clinics, ENTC specialist, and research institutes among others. The end-user segment is expected to hold the major market share for acute sinusitis market following a huge patient visits to the hospital for sinuses treatment.
The global acute sinusitis market regionally is segmented into North America, Europe, Asia-Pacific and Latin America, and the Middles East & Africa.
North America accounts for the largest share of the global sinusitis market. The growth in North America is uplifted by its technical progression in diagnostic services, increased expenditure, and easy access to healthcare facilities. Increasing prevalence of the chronic disease in the U.S. is boosting the market growth in the region. As per CDC, around 11% Americans are affected with acute sinusitis. Besides, emergency departmental visits, supportive test & measures, and overall sinusitis management expenses have also been increased in the U.S.
In the Asia Pacific, the prevalence of various acute and chronic diseases is increasing at an alarming rate. As per the Institute for Health Metrics and Evaluation, India holds 18% of the global population for chronic respiratory diseases. Moreover, rising demand for quality and cost-effective treatment is boosting the market growth in the region. Apart from this, growing number of patients suffering from sinusitis and easy treatment availability in the region are driving the market growth.
Some of the key players in the global acute sinusitis market include Sanofi(France), Bristol-Myers Squibb(U.S.), Reddy’s Laboratory(India), Eli Lilly and Company(U.S.), Abbott(U.S.), Bayer AG(Germany), Novartis AG(Switzerland), AstraZeneca Plc.(U.K.), and Merck & Co, Inc.(U.S.)
Our Report Covers
Acute Sinusitis Market Segmentation
o North America
o South America
o Western Europe
o Eastern Europe
o South Korea
o Rest of Asia Pacific
Middle East & Africa
o The Middle East